TY - CHAP
T1 - Structure-dynamic coupling through Ca2+-binding regulatory domains of mammalian NCX isoform/splice variants
AU - Khananshvili, Daniel
N1 - Publisher Copyright:
© Springer International Publishing AG, part of Springer Nature 2017.
PY - 2017
Y1 - 2017
N2 - Mammalian Na+/Ca2+ exchangers (NCX1, NCX2, and NCX3) and their splice variants are expressed in a tissue-specific manner and are regulated by Ca2+ binding CBD1 and CBD2 domains. NCX2 does not undergo splicing, whereas in NCX1 and NCX3, the splicing segment (with mutually exclusive and cassette exons) is located in CBD2. Ca2+ binding to CBD1 results in Ca2+-dependent tethering of CBDs through the network of interdomain salt-bridges, which is associated with NCX activation, whereas a slow dissociation of “occluded” Ca2+ inactivates NCX. Although NCX variants share a common structural basis for Ca2+-dependent tethering of CBDs, the Ca2+ off-rates of occluded Ca2+ vary up to 50-fold, depending on the exons assembly. The Ca2+-dependent tethering of CBDs rigidifies the interdomain movements of CBDs without any significant changes in the CBDs’ alignment; consequently, more constraining conformational states become more populated in the absence of global conformational changes. Although this Ca2+-dependent “population shift” is a common mechanism among NCX variants, the strength and span of backbone rigidification from the C-terminal of CBD1 to the C-terminal of CBD2 is exon dependent. The mutually exclusive exons differentially stabilize/destabilize the backbone dynamics of Ca2+-bound CBDs in NCX1 and NCX3 variants, whereas the cassette exons control the stability of the interdomain linker. The combined effects of mutually exclusive and cassette exons permit a fine adjustment of two different regulatory pathways: the Ca2+-dependent activation (controlled by CBD1) and the Ca2+-dependent alleviation of Na+-induced inactivation (controlled by CBD2). Exon-controlled dynamic features match with cell-specific regulatory requirements in a given variant.
AB - Mammalian Na+/Ca2+ exchangers (NCX1, NCX2, and NCX3) and their splice variants are expressed in a tissue-specific manner and are regulated by Ca2+ binding CBD1 and CBD2 domains. NCX2 does not undergo splicing, whereas in NCX1 and NCX3, the splicing segment (with mutually exclusive and cassette exons) is located in CBD2. Ca2+ binding to CBD1 results in Ca2+-dependent tethering of CBDs through the network of interdomain salt-bridges, which is associated with NCX activation, whereas a slow dissociation of “occluded” Ca2+ inactivates NCX. Although NCX variants share a common structural basis for Ca2+-dependent tethering of CBDs, the Ca2+ off-rates of occluded Ca2+ vary up to 50-fold, depending on the exons assembly. The Ca2+-dependent tethering of CBDs rigidifies the interdomain movements of CBDs without any significant changes in the CBDs’ alignment; consequently, more constraining conformational states become more populated in the absence of global conformational changes. Although this Ca2+-dependent “population shift” is a common mechanism among NCX variants, the strength and span of backbone rigidification from the C-terminal of CBD1 to the C-terminal of CBD2 is exon dependent. The mutually exclusive exons differentially stabilize/destabilize the backbone dynamics of Ca2+-bound CBDs in NCX1 and NCX3 variants, whereas the cassette exons control the stability of the interdomain linker. The combined effects of mutually exclusive and cassette exons permit a fine adjustment of two different regulatory pathways: the Ca2+-dependent activation (controlled by CBD1) and the Ca2+-dependent alleviation of Na+-induced inactivation (controlled by CBD2). Exon-controlled dynamic features match with cell-specific regulatory requirements in a given variant.
KW - Allosteric regulation
KW - Alternative splicing
KW - Dynamic coupling
KW - Exon
KW - HDX-MS
KW - NCX
KW - Population shift
KW - SAXS
UR - http://www.scopus.com/inward/record.url?scp=85044824771&partnerID=8YFLogxK
U2 - 10.1007/978-3-319-55858-5_3
DO - 10.1007/978-3-319-55858-5_3
M3 - ???researchoutput.researchoutputtypes.contributiontobookanthology.chapter???
C2 - 29594857
AN - SCOPUS:85044824771
T3 - Advances in Experimental Medicine and Biology
SP - 41
EP - 58
BT - Advances in Experimental Medicine and Biology
PB - Springer New York LLC
ER -